Philip Meuleman

6PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersEnvironmental studies in animal productionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiology not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 11, 2026
Fluorescent virus lights up on a new drug for chronic hepatitis E.

Jérôme Gouttenoire, Philip Meuleman

|May 03, 2025
Higher Hepatitis E Seroprevalence in Workers in the Pig Sector in Flanders, Belgium: Results From a Seroprevalence Case-Control Study.

Heidi Janssens, Lies Delameillieure, Stijn Jonckheere

|Aug 29, 2024
High-throughput single-cell screening of viable hybridomas and patient-derived antibody-secreting cells using punchable microwells.

Kaat Rubben, Ann-Sophie Vander Plaetsen, Ruben Almey

|Oct 13, 2023
The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus.

Laura Corneillie, Irma Lemmens, Claire Montpellier

|Aug 17, 2022
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.

Rani Burm, Panagiota Maravelia, Gustaf Ahlen

|Nov 05, 2020
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice.

Richard J P Brown, Birthe Tegtmeyer, Julie Sheldon

Pageof 1

Frequent Collaborators

1 joint publications

Richard J P Brown

1 joint publications

Birthe Tegtmeyer

1 joint publications

Tanvi Khera

1 joint publications

Daniel Todt